Introduction

Inflammation is a physiological defensive response of the body that plays a key role in protection against microbial infections and physical injury. In case of acute inflammation, onset is rapid and short, represented by liquid exudate, plasma proteins and leucocytes at site of injury. While the persistent inflammation for prolonged duration results in the chronic inflammation. It plays an important role in the pathogenesis of certain diseases like cancer, neuro degenerative disease, rheumatoid arthritis, obesity, cardiovascular diseases etc. (Bouyahya et al. 2022). Pain, edema redness and, sometimes, loss of the tissue functions due to change in blood flow, increased vascular tissue permeability and tissue destruction are the common characteristics of inflammation. All these changes occur due to activation and migration of leucocytes along with the production of reactive oxygen species (ROS), local inflammatory mediators, i.e., prostaglandins leukotrienes platelet activating factor induced by COX, LOX, and phospholipase A2. (Anyasor et al. 2019). ROS and other free radicals are involved in the pathogenesis of different inflammatory diseases. During inflammation, WBCs engaged at the damage site results in the production of cytokines (IL-1beta, IL-8, IL-6) and TNF alpha promoting cell activation and cell infiltration causing inflammation progression. Enzymes responsible for body defense mainly SOD, CAT and GSH fight against the oxidative stress, thus providing shield to the body against this oxidative imbalance (Kim et al. 2021). Research has indicated that inflammation can be effectively control by regulating the production of mediators and cytokines. In the present era, inflammation is being treated by various chemical-based drugs which possess many side effects including hepatotoxicity, cardiotoxicity, different immunological dysfunctions (Jan et al. 2020). Therefore, to avoid these side effects, researchers are being attracted by anti-inflammatory compounds from natural sources. A larger number of natural products particularly plants have been exhibiting excellent anti-inflammatory potentials both in vivo and in vitro (Miranda et al. 2013).

Bryophytes are small group of plants that lack true vascular system. They are rarely subjected to medicinal and chemical investigation. Several therapeutic compounds have been isolated from bryophytes like polysaccharides, terpenoids, amino acids, lipids, quinones, phenylpropanoids and other specialized metabolites. These compounds have been reported to possessed antimicrobial, antiviral, cytotoxic, nematocidal, insecticidal, effects on smooth and non-striated muscles, weight loss, plant growth regulators and allelopathic activities (Sabovljevic et al. 2017). Mosses are the major group of bryophytes that contribute significantly to the ecosystem supporting terrestrial biodiversity. In the past, mosses were used to cure wounds, burns, and many illnesses. Funaria is the largest genus in the moss family Funariaceae (Minozzomi et al. 2020). In ethnomedicine, it is frequently used for hemostasis, pulmonary tuberculosis, bruises and in skin infections (Yayintas and Irkin 2018). Many new biologically active compounds with potential for medicinal applications are derived from bryophytes, particularly moss and liverworts (Singh et al. 2007). Around 3.2% of mosses and 8.8% of liverworts have undergone chemical analysis. Funaria hygrometrica (FH) is found in the Punjab planes of Pakistan as a wild plant. The reports about the anti-inflammatory and analgesic potentials of this species and its mechanisms of action are lacking in the literature. The present study is innovated to vindicate the folk employment of FH by executing its anti-inflammatory and analgesic activeness scientifically.

Materials and methods

Plant materials

Whole Funaria hygrometrica (FH) plants were congregated from Khanspur and Nathigalli areas (in the northern region of Pakistan). The specimen of the plant species was identified and authenticated by Dr. Zaheer-ur-Khan, a plant taxonomist from Botany Department, Government College University Lahore. The plant specimen was deposited in the herbarium of Department of Botany, Government College University Lahore, Pakistan with voucher No. Cog-011 for further reference. The plant material was carefully dried, garbled, pulverized, and placed in a glass container.

Crude plant extract preparation

The grounded plant material (4 kg) was progressively macerated with n-hexane, chloroform, and methanol. The plant material was retained in each solvent for 7 days and 8 L of each solvent was utilized sequentially. Each solvent extract was inchoately percolated completely through muslin cloth, followed by filtering using Whatman-1 filter paper, and the filtration operation was repeated twice or three times to obtain the highest yield of each. Solvents from each extract was evaporated at low pressure (Abubakar et al. 2020). Resulting extracts, i.e., n-hexane, chloroform and methanol were light orange color, dark brown and greenish black in color, respectively. To obtain the semisolid extract, each extracted material underwent further drying in an oven set at 37 °C. Each extract was packaged with a label and stored between 25 and 30ºC. Chloroform extract (CE) was utilized for further investigation.

Chemicals and drugs

All chemicals were of analytical grade. These were formalin (Riedel–deHaen, Germany), carrageenan and acetic acid acetonitrile, formic acid (Sigma–Aldrich, USA). Diclofenac sodium was gifted from CCL Pharmaceuticals. Different doses of CE FH (100, 250 and 500 mg/kg) were prepared in 10% Tween 20 solution while diclofenac sodium 15 mg/kg were prepared in distilled water for administration.

UHPLC–MS analysis

Phytochemical profiling of CE FH was carried out using reverse-phase ultra-high-performance liquid chromatography mass spectrometry utilizing Agilent 1290 infinity UHPLC system coupled with Agilent 6520 accurate-mass Q-TOF mass spectrum equipped with dual ESI source. Agilent zorbax eclipse XDB-C18 (narrow19 bore 2.1 × 150 mm, 3.5 micron) was used for the analysis. Temperatures of the column and auto-sampler were maintained at 20 at 25 °C and 4 °C, respectively. Mobile phases X-formic acid (0.1% in water) and Y-acetonitrile (0.1%) were used at the rate of 0.5 mL/min during analysis. Each run was carried out for 25 min with injection volume of1.0 µL. Full-scan MS analysis was performed over the m/z 100–1000 range using an electrospray ion source in both negative mode and positive mode. Nitrogen was provided at flow rates of 25 and 600 L/hour, respectively, as nebulizing and drying gas (350 °C was the temperature of the drying gas). The voltage for fragmentation was calibrated to 125 V. An analysis was conducted using a 3500 V capillary voltage. Agilent Mass Hunter Qualitative Analysis B.05.00 was used to analyze the data (Method: Metabolomics3 2017-00.004.m). Compounds were identified by database search 4 METLIN AM PCDL-N- 170502.cdb: with parameters as: match tolerance 5 ppm, positive ions: + H, + Na, + NH4, negative-H (Saleem et al. 2020).

GC–MS analysis

GC–MS analysis was performed by Agilent-B-7890 equipped with mass spectrometer detector (5977-B using DB-5MS column having 100% dimethyl polysiloxane as stationary phase, having dimensions (L—30 m and D—0.25 mm) with pore size of 0.25 μm. The temperature of the injector was set at 250 °C, while an inter-phase temperature was 280° C. Helium was used as carrier gas and electron-impact ionization was used at −70 eV in full scan mood. Analysis time was 30 min. 2 μL of CE FH was performed in the split-less mode (Fan et al. 2021).

Experimental animals

Studies were conducted on albino rats weighing (150–200 g) and mice weighing 25–30 g of both the sexes. The animals were laid in Plexiglas cages (47 × 34 × 18 cm3) in the Research Laboratory of Pharmacology and Physiology, Faculty of Pharmacy, University of the Punjab Lahore, Pakistan. The laboratory temperature was sustained at 26 ± 2 °C and humidity was maintained at 50–55% along with 12-h light–dark cycle. All the animals were acclimatized for 7 days prior to study. They fed on standard animal feed and water ad libitum. All the experimental protocols were recapitulated by the Pharmacy Animal Ethics Committee with approval No. 2101 in the Faculty of Pharmacy, University of the Punjab Lahore, Pakistan.

Acute oral toxicity study

Using OECD criteria, the CE FH was assessed for acute oral toxicity prior to conducting the in vivo biological experiments (421 and 422). Mice were administered the extract at doses of 100, 250, 500, 750, 1000 and 2000 mg/kg for 14 days and after that, toxicity signs were noted. The mice were observed at 1-h interval for the first 12 h and daily, thereafter, for 14 days. The mortality was recorded after 48 h. The animals were observed for behavioral changes like tremors, convulsions, salivation, sweating, lacrimation, writhing reflex, convulsions, activity, and behavior pattern (Javed et al. 2020).

In vitro anti-inflammatory assay by inhibition of albumin denaturation

Anti-inflammatory activity was assessed using the inhibition of albumin denaturation technique (Leelaprakash et al. 2011). 5 mL of the reaction mixture consisted of 0.2 mL of eggs albumin (from hens’ egg), 2.8 mL of phosphate buffer saline (PBS, pH 6.4), and 2 mL of varying concentrations of the extract. A similar volume of double distilled water served as a control. Then, the mixture was incubated at 37 °C in a BOD incubator for about 15 min, then heated at 70 °C for 5 min. After cooling, the mixture absorbance was measured at 660 nm using against blank. Diclofenac sodium (standard drug) was used as a reference. The percentage inhibition of protein denaturation was calculated.

$${\text{Percentage inhibition }} = \, \left( {{\text{Abs control }}-{\text{Abs sample}}} \right) \, \times { 1}00/{\text{ Abs control}}{.}$$

In vivo anti-inflammatory assay

For anti-inflammatory activity, animals were divided into six groups and each group containing five animals. Group I (control) received vehicle, Group II (disease control) did not receive any oral treatment, Group III (standard) animals were administered diclofenac sodium 15 mg/kg orally, Group IV, Group V and Group VI received CE FH at doses of 100 mg/kg, 250 mg/kg and 500 mg/kg, respectively.

Carrageenan-induced hind paw edema

0.1 mL of freshly prepared 1% carrageenan was injected into the right hind paw of mice except the control group. The normal paw size of mice was measured with a digital vernier calliper (Mitutoyo, Japan). Half an hour earlier, the mice were given vehicle (orally), diclofenac sodium and various doses of a CE FH (100, 250 and 500 mg/kg, orally). Paw thickness (in mm) was again measured after carrageenan injection at 0 h up to 6 h. The percentage inhibition of the paw was calculated according to the previously reported formula (Sudjarwo et al. 2005).

$${\text{Percentage inhibition }} = \frac{{{\text{controlled mean }}-{\text{ treated mean}}}}{{{\text{controlled mean}} \times {1}00}}.$$

Formalin-induced edema in rat paw

Chronic anti-inflammatory consequences of different dosses of CE FH were evaluated by formaldehyde induced rat paw edema by following formerly delineate method.

Edema was induced by injecting 0.1 mL of 2% formaldehyde solution in distilled water into sub-planer region of hind paw of each mouse except for the control group (group-I) and repeated induction on day 3. Vehicle (group-I), disease control (group-II), diclofenac sodium 15 mg/kg as a standard drug (group-III) and the CE FH at the dosses of 100, 250 and 500 mg/kg/mL (group IV, group V and group VI) were administrated orally one hour prior to injecting the formaldehyde solution. Drug treatment was prolonged for 10 days. Paw thickness was measured from 0 to 10 days with a digital vernier caliper and edema was calculated (Chang et al. 2012). Percentage inhibition of paw edema was calculated using the above-mentioned equation. At the end of the 10-day study, the rats were killed, and blood was collected in serum tubes and centrifuged at 3000 rpm for 10 min at room temperature to obtain the serum. The serum was then tested for the presence of serum enzymes like catalase (CAT), superoxide dismutase (SOD), and glutathione (GSH) (John et al. 2012). In addition, TNF-α, IL-6, IL-4, IL-10, and hematological assays were also performed as described below.

Estimation of TNF-α, IL-6, IL-4 and IL-10

The quantitative analysis of inflammatory mediator gene expression was performed with optimized qRT-PCR. The extraction of total RNA from blood samples treated was performed with a multi-type sample DNA/RNA extraction purification kit (Sansure Biotech Inc, China). The reverse transcription of RNA samples to cDNA was performed with Thermo-First cDNA kit (HRP013 100 T, ZOKEYO, China). A 2X SYBR qPCR Mixture (Zokeyo, China) containing a total reaction volume of 15 μL (10 μL of SYBR Green mix, primers at 0.5 μM each and 1 μL of cDNA as template with relevant primers in duplicates) was run in SLAN-96P Real-Time PCR System (Sansure Biotech Inc, China). The microplate was kept at 95 °C for 30 s for initial denaturation and annealing process occurred at 95 °C for 5 s and extension phase was carried out at 60 °C for 20 s. The relevant Ct’s of samples were compared against controls and control samples containing housekeeping genes (GAPDH) (Table 1).

Table 1 Primers sequence used in qRT-PCR

Hematological studies

Rats were anesthetized with ketamine + xylazine and blood was drawn for biochemical evaluation by heart puncture following ten days of formalin-induced rat paw edema study. Some of the collected blood was used to perform hematological studies like complete blood count and CRP mg/L (Peerzada et al. 2020).

Analgesic activity

Mice (14–28 g) were used to determine the analgesic effect of CE FH by hot-plate and tail immersing test. Mice were divided into five groups containing five animals each. Vehicle was given to the control group, diclofenac sodium in 15 mg/kg was given to the standard group, while treated groups were administered 100, 250 and 500 mg/kg of the extract orally.

Hot-plate method

Hot-plate assay was performed by treating mice with different treatments and after 1 h of treatment/doses, the individual mouse from each group was put on the hot plate (VELP®, Italy) at fixed temperature of 50–55 °C. The pain latency time for the mice to show response by paw licking, lifting, or jumping was noted. The reaction time before the treatment and after 30, 60, 90 and 120 min of drug administration was recorded. 25 s was taken as cut-off time to prevent the injury to the paw (Javed et al. 2020).

Tail flicking method

A thermostat was adjusted to maintain the temperature of the water heater at 50–55 °C. The tail of the mice (3 cm) was dipped in hot water and the reaction time of tail withdrawing from hot water was noted. After that, testing drugs and different doses of the extract (100, 250 and 500 mg/kg) were given to the experimental animals to find out the reaction time again at 30, 60, 90 and 120 min. 25 s was taken as cut-off time to avoid the damage the tissues (Bhukya et al. 2009).

Statistical analysis

Result values were represented in mean ± SEM (n = 5). Two-way ANOVA followed by post hoc Dunnett’s test was performed using Graph Pad Prism 9 (San Diego, CA, USA) software. p-value of less than 0.05 was considered statistically significant.

Results

UHPLC–MS profiling

It is not feasible to evaluate the pharmacological effects of plant extracts without analyzing their chemistry. The bioactive chemicals that naturally occur are typically what determines the biological potential of therapeutic plants. So, both positive and negative ionization modalities of UHPLC–MS analysis of CE FH were performed to acquire an in-depth identification. The tentative presence of 30 distinct chemicals was detected in the CE FH, as stated in Table 2 and the total ion chromatograms (TICs) are displayed in Fig. 1.

Table 2 UHPLC–MS analysis of CE FH
Fig. 1
figure 1

Total ion chromatograms of CE FH

GC–MS analysis

26 compounds were detected in GC–MS analysis. Many of these compounds have reported anti-inflammatory and analgesic properties Table 3 (Fig. 2).

Table 3 Components detected in CE FH by GC–MS analysis
Fig. 2
figure 2

G–MS spectra of CE FH

Acute toxicity

Acute toxicity observations in mice with increasing doses of crude plant extract up to 2000 mg/kg were noted and found to be safe. There was no sign of toxicity in terms of altered behavior or mortality after 48 h.

Anti-inflammatory assay

In vitro anti-inflammatory assay

In the current study's in vitro anti-inflammatory test, the CE FH demonstrated a mean inhibition of protein denaturation of 15, 20, 27.50, 32.50, 40.00, 47.25 and 52.75% for doses of 50, 100, 150, 200, 250, 300 and 350 µg/mL, respectively; while, the standard diclofenac sodium showed a mean inhibition of protein denaturation of 25.26, 29.75, 36.25, 41.74, 47.00, 55.10 and 63.00% (Table 4). With a linear response, the CE FH demonstrated good anti-inflammatory action. Diclofenac sodium a common anti-inflammatory medicine, displayed the highest level of inhibition at 350 µg/ml.

Table 4 Inhibition of protein denaturation assay of CE FH

Carrageenan-induced hind paw edema

The results indicated that CE FH extract had an anti-inflammatory effect at different doses (100, 250, and 500 mg/kg). Maximum reduction in inflammation was observed at 5th hour at the dose 100 mg/kg while at doses 250 and 500 mg/kg maximum response was observed at 5th and 6th hours. The standard drug exhibits a significant anti-inflammatory response from 4 to 6 h (Fig. 3).

Fig. 3
figure 3

Paw diameter in carrageenan-induced edema was significantly reduced in the carrageenan-induced inflammation analysis at various plant dosages extract. Every result value is expressed in mean and SEM. n = 5. p < 0.05 (*) in comparison to the controlled group. Two-way ANOVA is applied using post hoc Dunnett’s test. All the groups are compared with disease control at one time interval

Formalin-induced rat paw edema

The formalin-induced mice paw edema showed a significant decrease (p < 0.05) in the paw size and diameter after 5 days treatment with CE FH (Fig. 4). The administration of formalin resulted in an increase in the level of leucocytes, total WBC, CRP in control group, while a decrease in the level of these parameters were observed with CE FH pre-treatment (Tables 5, 6). Formalin processed experimental animals exhibited a diminution in the levels of SOD, GSH, CAT, total RBC and Hb and these parameters in animals pre-treated with CE FH at dose levels of 100, 250 and 500 mg/kg were significantly normalized (Fig. 5). Acute inflammatory mediators such as TNF, IL-6, IL-were reduced and IL-10 up regulated in the treated group as compared to the control (Fig. 6).

Fig. 4
figure 4

Paw thickness in formalin-induced edema was significantly reduced by various plant extract dose treatments. Every result value is expressing in mean and SEM. n = 5. p < 0.05 (*) in comparison to the controlled group. Two-way ANOVA is applied using post hoc Dunnett’s test. All the groups are compared with disease control at one time interval

Table 5 Effect of CE FH on complete blood count in experimental animals
Table 6 Levels of leucocytes and CRP in experimental animals
Fig. 5
figure 5

Level of catalase (A), SOD (B), Glutathione (C), MDA (D) in experimental animals. Two-way ANOVA is applied using Post-hoc Dunnett’s test. All the groups are compared with disease control at one time interval

Fig. 6
figure 6

Genetic expression changes in IL-4 (A), IL-6 (B), TNF-α (C), IL-10 (D) in various treated experimental groups. Two-way ANOVA is applied using post hoc Dunnett’s test. All the groups are compared with disease control at one time interval

Analgesic activity

Hot-plate method

At various time intervals (30, 60, 90, and 120 min), the CE FH displayed considerable pain dormancy at doses of 100, 250, and 500 mg/kg. Results indicated that maximum analgesia was observed up to 120 min at 100 mg/kg while up to 90 min in case of 250 and 500 mg/kg doses. Diclofenac sodium, a standard medication, also greatly lessens the pain throughout all observational intervals (Fig. 7).

Fig. 7
figure 7

Latency time in different treatment groups, tail-immersion method (A), tail-flick method (B) at various time intervals. All resulted values are mentioned in mean ± SEM; n = 5. p < 0.05 (*) when compared to control group

Tail flick method

Tail immersion method was used to assess the analgesic effect, and all dosages (100, 250 and 500 mg/kg) significantly reduced pain latency compared to the control (Fig. 7).

Discussion

Ethnobotanical investigations have shown that many plants are employed traditionally in various regions of the world as analgesics and anti-inflammatory agents (Yu et al.2019; Paramita et al 2017). The current study was designed to substantiate scientifically the traditional usage of Funaria hygrometrica. In vitro protein (albumin) denaturation assay is based upon the formation of antigens that triggers type III hypersensitivity reactions resulting in inflammation. Percent inhibition of albumin denaturation is directly linked with the anti-inflammatory potentials.

The chloroform extract of Funaria hygrometrica (CE FH) inhibited protein denaturation and the results were comparable with standard diclofenac sodium (Table 4). From the results of a linear response, the CE FH demonstrated significant in vitro anti-inflammatory action.

Hot-plate and tail-flick assays were employed to evaluate the central analgesic effectiveness of CE FH. These are acute models of pain and both types of stimuli induce pain by heat-mediated damage of tissues and are selective for chemicals like opioids (Andurkar and Gulati 2011). Results revealed that mice treated with doses of 100, 250, and 500 mg/kg of CE FH (Fig. 7) experienced a significant analgesic effect (p < 0.05) which may be due to the presence of components identified by UHPLC–MS and GC–MS analysis (Tables 2, 3). Fumaric acid (Shakya et al. 2014), steroids like stigmasterol and campesterol (Toma et al. 2003), Benzoic acid, 3,5-dicyclohexyl-4-hydroxy-, methyl ester (Subramanian et al. 2020) elucidated by UHPLC–MS may contribute to the analgesic activity. Fumaric acid or its esters have frequently been identified as the bioactive components of various medicinal plants, and it has long been recognized that fumaric acid has antioxidant, anti-inflammatory and analgesic potential (Shakya et al. 2014).

Carrageenan-induced paw edema is a well-established model of acute inflammation which induces biphasic acute inflammatory response with the release of histamine, serotonin, kinins in the first phase and later prostaglandins (Yu et al. 2019). The clinically relevant steroidal and nonsteroidal anti-inflammatory drugs can have an impact on the second phase (Amdekar et al. 2011). Our results showed that CE FH significantly reduced the inflammation caused by carrageenan (Fig. 3) which may have blocked the production of prostaglandins in the second phase of acute inflammation. The phytochemical profiling by GC–MS and UHPLC–MS identified presence of established anti-inflammatory compounds like Hexadecanoic acid, Phytol, chlorovulone III (Ciufolini and Zhu 1998), γ-Tocotrienol (Yap et al. 2008), emmotin A (Da Silva et al 2012) and cassine (John and shobana 2012). Hexacosanedioic, a specific inhibitor of phospholipase A2, decreases inflammation through suppression of arachidonic acid pathway (Aparna, et al. 2012). Phytol also possesses prominent antioxidant and anti-inflammatory potential (Silva et al. 2014). Stigmasterol interacts with glucocorticoid receptors, thereby suggesting that the CE FH extract may interact with these receptors and reduces inflammatory burden (Maceyka and Speigel 2014).

In the current study, chronic inflammation was induced with formalin. In-inflammatory conditions, there is excessive superoxide radical production which can cause tissue damage through the production of hydrogen peroxide and hydroxy radicals responsible for membrane destruction (Jantaratnotai et al. 2022). Amongst the antioxidant enzymes, SOD is the most significant enzyme present in mitochondria and protects against superoxide anions. Glutathione is another essential endogenous antioxidant that functions as part of the glutathione redox system to protect cells from oxidative damage. Tissue glutathione depletion induces lipid peroxidation in the cells (Allagui et al. 2022). Our results showed that CE FH treatment significantly upregulated antioxidant enzymes (Fig. 5). Therefore, it could be suggested that CE FH protects against oxidative damage in chronic inflammation. Inflammatory mediators were also downregulated with prior CE FH treatment as compared to the diseased group (Fig. 6). The levels of inflammatory mediators including IL-6, IL-4 and TNF-α were declined and IL-10 was increased. IL-10 is a powerful macrophage deactivator that prevents human monocytes from producing TNF α, IL-1, IL-6, IL-4, or GM-CSF (Trushin et al. 2003).

Stigmasterol and campesterol detected in GC–MS analysis downregulated the mRNA expression of IL-6 and TNF-α reported in previous studies (Bakrim et al. 2022; Utami et al. 2020) and our results coincide with these findings (Fig. 6). Hematological findings supported the protective effect of CE FH on different parameters like RBC, hemoglobin, WBC and C-reactive protein. RBC and hemoglobin are important components of the oxygen transport system. Formalin treatment causes reduction in the RBC and Hb level which can lead to anemia (John and Shobana 2012). These levels were returned to normal after pre-treatment with the CE FH in various doses (100, 250 and 500 mg/kg, Table 5). WBCs are the key element of the body's defence system and increase in WBC count during inflammation occurs due to increased concentration of interleukins and macrophages. The current investigation showed that formalin administration elevates the count of neutrophils, eosinophils, and C-reactive protein. Different doses of CE FH (100, 250 and 500 mg/kg) lowered the neutrophil and eosinophil populations along with decrease in C-reactive protein (Table 6) indicating a considerable reduction in the inflammatory process (John and Shobana 2012). Terpenoids, hydrocarbons, esters, and fatty acids detected in phytochemical analysis are some of the phytoconstituents that have beneficial pharmacological effects in acute and chronic inflammation (Andrikopoulos et al. 2003).

Conclusion

The current phytochemical and biochemical investigations point to the potential analgesic and anti-inflammatory action of CE FH. Therefore, it can be concluded that this plant will make a viable choice for the treatment of illnesses linked to inflammation and pain. However, further investigation of molecular targets reducing inflammation may be elucidated in future.